Clinical Trial Update: Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating metformin for chemoprevention of lung cancer in overweight or obese individuals at high risk; the Northwestern University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Northwestern University | Conditions: Lung Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING